Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_002462.5(MX1):c.448A>G(p.Ile150Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
MX1 (HGNC:7532): (MX dynamin like GTPase 1) This gene encodes a guanosine triphosphate (GTP)-metabolizing protein that participates in the cellular antiviral response. The encoded protein is induced by type I and type II interferons and antagonizes the replication process of several different RNA and DNA viruses. There is a related gene located adjacent to this gene on chromosome 21, and there are multiple pseudogenes located in a cluster on chromosome 4. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2013]
Review Status: criteria provided, single submitter
Collection Method: clinical testing
The c.448A>G (p.I150V) alteration is located in exon 10 (coding exon 4) of the MX1 gene. This alteration results from a A to G substitution at nucleotide position 448, causing the isoleucine (I) at amino acid position 150 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Gain of ubiquitination at K145 (P = 0.1446);Gain of ubiquitination at K145 (P = 0.1446);Gain of ubiquitination at K145 (P = 0.1446);Gain of ubiquitination at K145 (P = 0.1446);Gain of ubiquitination at K145 (P = 0.1446);.;Gain of ubiquitination at K145 (P = 0.1446);